Denmark· DK-28105194512
Cleareyes
A naphazoline product containing naphazolinhydrochlorid, registered in Denmark by Elara Pharmaservices Europe Ltd.. The same ATC class is registered in 8 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Naphazoline is registered in 8 of 19 countries.
Countries holding a registration under ATC S01GA01 (naphazoline), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 4 of them publish a price we can compare per daily dose
Naphazoline · ATC S01GA01
8 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Norwayprice
- United Kingdom
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Naphazolinhydrochlorid
- Manufacturer
- Elara Pharmaservices Europe Ltd.
- Country
- Denmark (DK)
- ATC code
- S01GA01
- ATC class
- Naphazoline
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28105194512
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
53 interactions on record for naphazoline.
Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Naphazoline · interactions on record
53 records
- 7 severe
- 46 moderate
Most severe, free to view
- MethylergometrineG02AB01severe
- ErgometrineG02AB03severe
- DihydroergotamineN02CA01severe
- ErgotamineN02CA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under S01GA01
Naphazoline, as other registers publish it.
- CanadaALBALONABBVIE CORPORATION
- CanadaCLEAR EYESPRESTIGE BRANDS INC
- FinlandCleariElara Pharmaservices Europe Limited
- IcelandCleyeElara Pharmaservices Europe Limited
- NorwayCleyeElara Pharmaservices Europe Ltd
- CanadaCOLLYRE BLEU LAITERFRILAB SA
- United KingdomMurine irritation & redness relief 0.012% eye dropsPrestige Brands (UK) Ltd
- IrelandMurine irritation & redness relief, 0.012% w/v, eye drops solutionElara Pharmaservices Europe Limited
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/131b8870-79a5-40c6-b10d-dfd0d5f94c8f GET /v1/drugs/131b8870-79a5-40c6-b10d-dfd0d5f94c8f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "øjendråber, opløsning",
"source": "dkma",
"strength": "0,12 mg/ml",
"auth_role": "RMS",
"dk_drugid": "28105194512",
"substance": "Naphazolinhydrochlorid",
"auth_procedure": "Decentral procedure",
"in_medicinpriser": false,
"registration_date_serial": "41956"
}See everything about naphazoline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.